Literature DB >> 21762254

A new approach for the comparison of conduction abnormality between arrhythmogenic right ventricular cardiomyopathy/dysplasia and Brugada syndrome.

Kenji Yodogawa1, Norishige Morita, Yoshinori Kobayashi, Hideo Takayama, Toshihiko Ohara, Yoshihiko Seino, Takao Katoh, Kyoichi Mizuno.   

Abstract

BACKGROUND: Right ventricular outflow tract ventricular tachycardia (RVOT-VT), arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/ARVD), and Brugada syndrome (BrS) were characterized by arrhythmias originating in the right ventricle, and the pathophysiologic mechanism underlying these arrhythmias has not been fully understood.
METHODS: This study consisted of 40 subjects, including 20 patients with RVOT-VT, 10 patients with BrS, and 10 ARVD patients. The parameters on the signal-averaged electrocardiography (ECG) and the frequency components recorded from the wavelet-transformed ECG were compared between the three groups. Late potentials were positive in none of the patients with RVOT-VT, seven of the patients with BrS, and all of ARVD patients.
RESULTS: In Brugada and ARVD patients, the power of high-frequency components (80-150 Hz) was developed to a greater extent than in RVOT-VT patients. In the power analysis of the high-frequency components between BrS and ARVD, the frequency showing the greatest power was significantly higher in ARVD patients than that in BrS patients (145.4 ± 27.9 Hz vs 81.7 ± 19.9 Hz, P < 0.01).
CONCLUSIONS: High-frequency components were developed in ARVD and BrS, but not in RVOT-VT. The frequency levels showing high power by wavelet analysis obviously differ between ARVD and BrS. Wavelet analysis may provide new insight into unsolved mechanisms in arrhythmogenic right heart disease. ©2011, Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21762254      PMCID: PMC6932736          DOI: 10.1111/j.1542-474X.2011.00441.x

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  18 in total

1.  Detection of abnormal high-frequency components in the QRS complex by the wavelet transform in patients with idiopathic dilated cardiomyopathy.

Authors:  K Maehara; T Kokubun; N Awano; K Taira; M Ono; T Furukawa; Y Shimizu; Y Maruyama
Journal:  Jpn Circ J       Date:  1999-01

2.  Late potentials and the Brugada syndrome.

Authors:  Charles Antzelevitch
Journal:  J Am Coll Cardiol       Date:  2002-06-19       Impact factor: 24.094

3.  Predictive value of wavelet decomposition of the signal-averaged electrocardiogram in idiopathic dilated cardiomyopathy.

Authors:  G Yi; K Hnatkova; N G Mahon; P J Keeling; M Reardon; A J Camm; M Malik
Journal:  Eur Heart J       Date:  2000-06       Impact factor: 29.983

Review 4.  Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association.

Authors:  Charles Antzelevitch; Pedro Brugada; Martin Borggrefe; Josep Brugada; Ramon Brugada; Domenico Corrado; Ihor Gussak; Herve LeMarec; Koonlawee Nademanee; Andres Ricardo Perez Riera; Wataru Shimizu; Eric Schulze-Bahr; Hanno Tan; Arthur Wilde
Journal:  Circulation       Date:  2005-01-17       Impact factor: 29.690

5.  Wavelet analysis of high-resolution signal-averaged ECGs in postinfarction patients.

Authors:  D Morlet; F Peyrin; P Desseigne; P Touboul; P Rubel
Journal:  J Electrocardiol       Date:  1993-10       Impact factor: 1.438

6.  Genetic basis and molecular mechanism for idiopathic ventricular fibrillation.

Authors:  Q Chen; G E Kirsch; D Zhang; R Brugada; J Brugada; P Brugada; D Potenza; A Moya; M Borggrefe; G Breithardt; R Ortiz-Lopez; Z Wang; C Antzelevitch; R E O'Brien; E Schulze-Bahr; M T Keating; J A Towbin; Q Wang
Journal:  Nature       Date:  1998-03-19       Impact factor: 49.962

7.  Wavelet decomposition analysis of the signal averaged electrocardiogram used for risk stratification of patients with hypertrophic cardiomyopathy.

Authors:  A Englund; K Hnatkova; P Kulakowski; P M Elliot; W J McKenna; M Malik
Journal:  Eur Heart J       Date:  1998-09       Impact factor: 29.983

8.  Results of ajmaline testing in patients with arrhythmogenic right ventricular dysplasia-cardiomyopathy.

Authors:  Stefan Peters; Martina Trümmel; Stefan Denecke; Brigitte Koehler
Journal:  Int J Cardiol       Date:  2004-06       Impact factor: 4.164

9.  Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology.

Authors:  W J McKenna; G Thiene; A Nava; F Fontaliran; C Blomstrom-Lundqvist; G Fontaine; F Camerini
Journal:  Br Heart J       Date:  1994-03

10.  Cardiac histological substrate in patients with clinical phenotype of Brugada syndrome.

Authors:  Andrea Frustaci; Silvia G Priori; Maurizio Pieroni; Cristina Chimenti; Carlo Napolitano; Ilaria Rivolta; Tommaso Sanna; Fulvio Bellocci; Matteo Antonio Russo
Journal:  Circulation       Date:  2005-12-13       Impact factor: 29.690

View more
  3 in total

1.  Mechanisms Underlying Epicardial Radiofrequency Ablation to Suppress Arrhythmogenesis in Experimental Models of Brugada Syndrome.

Authors:  Bence Patocskai; Namsik Yoon; Charles Antzelevitch
Journal:  JACC Clin Electrophysiol       Date:  2016-12-21

Review 2.  Right Ventricular Outflow Tract Arrhythmias: Benign Or Early Stage Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia?

Authors:  Tina Lin; Sergio Conti; Laura Cipolletta; Vittoria Marino; Martina Zucchetti; Eleonora Russo; Francesca Pizzamiglio; Ghaliah AlMohani; Salvatore Pala; Valentina Catto; Luigi Di Biase; Andrea Natale; Claudio Tondo; Corrado Carbucicchio
Journal:  J Atr Fibrillation       Date:  2014-12-31

Review 3.  New electrocardiographic features in Brugada syndrome.

Authors:  Antonio B de Luna; Javier Garcia-Niebla; Adrian Baranchuk
Journal:  Curr Cardiol Rev       Date:  2014-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.